Provided by Tiger Trade Technology Pte. Ltd.

XILIO THERAPEUTICS, INC.

9.01
+0.10001.12%
Post-market: 9.010.00000.00%19:30 EDT
Volume:7K
Turnover:66.47K
Market Cap:59.29M
PE:-2.72
High:9.08
Open:8.89
Low:8.89
Close:8.91
52wk High:12.58
52wk Low:6.47
Shares:6.58M
Float Shares:3.40M
Volume Ratio:1.03
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3174
EPS(LYR):-15.2374
ROE:-55.03%
ROA:-13.61%
PB:0.82
PE(LYR):-0.59

Loading ...

Xilio Therapeutics Files Beneficial Ownership Form 3 for Chief Medical Officer Yariv Houvras

Reuters
·
Yesterday

Xilio Therapeutics Grants Inducement Stock Options for 205,895 Shares at $8.91 Each

Reuters
·
Yesterday

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Reuters
·
Sep 28

Xilio Therapeutics Appoints Yariv J. Houvras, M.d., Ph.d. as Chief Medical Officer

THOMSON REUTERS
·
Sep 28

Press Release: Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer

Dow Jones
·
Sep 28

Xilio Therapeutics Grants Inducement Stock Options for 19,865 Shares at $8.88 Each

Reuters
·
Sep 03

Xilio Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 03

Xilio Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Xilio Therapeutics Inc Expected to Post a Loss of 92 Cents a Share - Earnings Preview

Reuters
·
Aug 12

Xilio Therapeutics - Plans to Report Initial Phase 1 Data in Patients with Metastatic Nsclc in H2 2027

THOMSON REUTERS
·
Aug 12

Xilio Therapeutics - Expects Cash Runway into Q1 2028

THOMSON REUTERS
·
Aug 12

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

THOMSON REUTERS
·
Aug 12

Xilio Therapeutics Grants Inducement Stock Options for 107,060 Shares at $9.22 Each

Reuters
·
Jul 07

Xilio Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 07

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer

THOMSON REUTERS
·
Jun 29

Xilio Therapeutics Adjusts Board Structure Following Shareholder Votes

TIPRANKS
·
Jun 13

Xilio Therapeutics shareholders approved amended and restated 2021 stock incentive plan update

Reuters
·
Jun 13

Xilio Therapeutics files $250M mixed securities shelf

TIPRANKS
·
May 13

Xilio Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 12

Xilio Therapeutics Inc - May Offer up to $17.22 Mln Common Stock Under Sales Agreement With Leerink Partners - SEC Filing

THOMSON REUTERS
·
May 12